Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: justification for risk-adapted therapy
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: John G Gribben Michael R Grever Nyla A Heerema Gerard Lozanski Bercedis Peterson John C. Byrd Michael A Caligiuri Richard A. Larson |
| Publication date | December 12, 2005 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |